These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6752560)

  • 1. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
    Witzgall H; Thayil G; Weber PC
    Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
    Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
    Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity.
    Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J
    Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin, aldosterone and other mineralocorticoids in hyperkalemic patients with chronic renal failure showing mild azotemia.
    Saruta T; Nagahama S; Eguchi T; Oka M; Kanbegawa A
    Nephron; 1981; 29(3-4):128-32. PubMed ID: 7035983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.
    Scherer B; Witzgall H; Weber PC
    Klin Wochenschr; 1984 Aug; 62(16):777-82. PubMed ID: 6384651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism.
    Shimizu Y; Hanew K; Sato S; Sasaki A; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Sep; 144(1):33-42. PubMed ID: 6506061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
    Holland OB; Chud JM; Braunstein H
    J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of serum angiotensin I-converting enzyme in essential hypertension].
    Gotoh M
    Nihon Naibunpi Gakkai Zasshi; 1985 Dec; 61(12):1341-57. PubMed ID: 3005063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
    Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H
    Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paper chromatographic systems for the separation of aldosterone, 18-hydroxycorticosterone, 18-hydroxydeoxycorticosterone, corticosterone and deoxycorticosterone.
    Witzgall H; Hassan-Ali S
    J Chromatogr; 1980 Sep; 198(1):70-5. PubMed ID: 7430313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism].
    Shimizu Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Jan; 60(1):1-15. PubMed ID: 6745468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
    Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
    Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
    Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
    Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia.
    Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE
    J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III].
    Itoh N
    Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):419-38. PubMed ID: 3410145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do weak mineralocorticoids affect the pathogenesis of hypertension in Cushing's disease?
    Hermus A; Hobma S; Pieters G; Benraad T; Smals A; Kloppenborg P
    J Hypertens Suppl; 1989 Dec; 7(6):S208-9. PubMed ID: 2698926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma mineralocorticoids, plasma renin, and urinary kallikrein in salt-sensitive and salt-resistant rats.
    Rapp JP; Tan SY; Margolius HS
    Endocr Res Commun; 1978; 5(1):35-41. PubMed ID: 710365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of alterations of the renin-angiotensin system and the sympathetic nervous system on plasma bradykinin concentration in patients with essential hypertension].
    Takeda Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1112-24. PubMed ID: 6097486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.